APR-246 increases tumor antigenicity independent of p53

Judith Michels(Cornell University), Taha Merghoub(Weill Cornell Medicine)

Life Science Alliance

October 27, 2023

10.26508/lsa.202301999

Cited by 5

Related Papers

CTLA-4 blockade drives loss of Treg stability in glycolysis-low tumours

|Nature|2021|389

T cell immunotherapies engage neutrophils to eliminate tumor antigen escape variants

|Cell|2023|290

Pharmacologic LDH inhibition redirects intratumoral glucose uptake and improves antitumor immunity in solid tumor models

|Journal of Clinical Investigation|2024|65

Intermittent MEK Inhibition with GITR Costimulation Rescues T-cell Function for Increased Efficacy with CTLA-4 Blockade in Solid Tumor Models

|Cancer Immunology Research|2024|7